Home > Innovative therapies for skin diseases > icon-speech-bubble
Published on 09/06/2020
icon-speech-bubble
Related News
AlmirallShare new call is seeking new partenship opportunities for preclinical and clinical stage assets that can become new treatments for skin diseases
Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo
Related News
Published on 20/07/2022
AlmirallShare 7th call is out now!
AlmirallShare new call is seeking new partenship opportunities for preclinical and clinical stage assets that can become new treatments for skin diseases
Published on 20/05/2022
Innovative therapies for vitiligo
Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo
Published on 20/03/2022
Understanding hidradenitis suppurativa
Almirall announces a collaboration with the University of Michigan to gain understanding of disease drivers in hidradenitis suppurativa
icon-speech-bubble